ArticlesFull Access
Published Online:27 Sep 2023https://doi.org/10.1176/appi.ajp.20220660
- Cited by
- Rona J. Strawbridge,
Ph.D. , - Nicholas Graham,
M.B.Ch.B., Ph.D.
1 November 2023 | American Journal of Psychiatry, Vol. 180, No. 11- Rona J. Strawbridge,
- Ned H. Kalin,
M.D.
1 November 2023 | American Journal of Psychiatry, Vol. 180, No. 11- Ned H. Kalin,
Metrics
The authors thank the research participants contributing to the genome-wide association studies (GWASs) used for the present study, including the GWASs of schizophrenia from Psychiatric Genomics Consortium and the GWASs of coronary artery disease and cardiovascular disease risk factors. This research was conducted using data from the UK Biobank, a major biomedical database, under accession number 27412 (www.ukbiobank.ac.uk). This work was performed on the Tjeneste for Sensitive Data (TSD) platform, owned by the University of Oslo and operated and developed by the TSD service group at the University of Oslo, IT-Department ([email protected]).
History
Received 1 August 2022
Revised 23 April 2023
Accepted 26 May 2023
Published online 27 September 2023
Published in print 1 November 2023